GLP-1, Diabetes, and Cognitive Decline
Author Information
Author(s): Mossello Enrico, Ballini Elena, Boncinelli Marta, Monami Matteo, Lonetto Giuseppe, Mello Anna Maria, Tarantini Francesca, Baldasseroni Samuele, Mannucci Edoardo, Marchionni Niccolò
Primary Institution: University of Florence and Careggi Teaching Hospital
Hypothesis
The study investigates the potential link between glucagon-like peptide-1 (GLP-1) dysfunction and cognitive decline in Type 2 diabetes mellitus (T2DM).
Conclusion
The study suggests that GLP-1 dysfunction may mediate the relationship between T2DM and cognitive decline, indicating potential therapeutic opportunities.
Supporting Evidence
- GLP-1 levels are reduced in Type 2 diabetes, which may affect brain health.
- Studies suggest that GLP-1 may have neuroprotective effects against Alzheimer's disease.
- GLP-1 analogues have shown promise in enhancing cognitive function in animal models.
Takeaway
This study looks at how a hormone called GLP-1, which helps control blood sugar, might also protect our brain from problems like Alzheimer's disease, especially in people with diabetes.
Methodology
The study reviews experimental research linking GLP-1 dysfunction to cognitive decline in T2DM.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website